Emcure Pharmaceuticals Profit & Loss Annual

BSE: 544210 | NSE: EMCURE | ISIN: INE168P01015 | Sector: -
1,310.10 -14.20 (-1.07%)Updated : 20 Jun 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Revenue 7,896.006,658.255,985.815,855.39
Total Revenue 7,896.006,658.255,985.815,855.39
Costof Revenue Total 3,146.602,595.462,369.112,330.43
Gross Profit 4,749.394,062.793,616.703,524.95
Selling/ General/ Admin Expenses Total 1,446.291,913.311,605.411,408.80
Depreciation/ Amortization 384.13312.41260.12244.86
Unusual Expense( Income) 10.389.936.15-
Other Operating Expenses Total 1,834.25919.76829.78785.84
Total Operating Expense 6,821.655,750.875,070.564,769.93
Operating Income 1,074.35907.39915.251,085.46
Interest Inc( Exp) Net- Non- Op Total -170.26-166.08-153.03-96.58
Other Net 67.26-21.27-14.68-15.92
Net Income Before Taxes 971.35727.23747.21972.55
Provisionfor Income Taxes 263.88199.65185.37269.99
Net Income After Taxes 707.47527.58561.85702.56
Minority Interest -26.14-29.39-29.83-40.36
Net Income Before Extra Items 681.33498.18532.02662.20
Net Income 681.33498.18532.02662.20
Income Availableto Com Excl Extra Ord 681.33498.18532.02662.20
Income Availableto Com Incl Extra Ord 681.33498.18532.02662.20
Diluted Net Income 681.33498.18532.02662.20
Diluted Weighted Average Shares 18.7018.9118.9118.91
Diluted EPS Excluding Extra Ord Items 36.4326.3528.1335.02
DPS- Common Stock Primary Issue 3.00---
Diluted Normalized EPS 36.8326.4528.3935.03
period Length 12.0012.0012.0012.00
period Type ----
Gain( Loss)on Saleof Assets -7.19-0.33-0.41
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,936.95+61.35(3.27%)
12,803.60-2.55 (-0.02%)